This webinar has concluded — a recording is available
A recording of this webinar can be accessed on BCPhA’s e-learning platform.
Members can access for free on our eTraining Portal.
How has the COVID-19 pandemic impacted people who use drugs? Why was the new clinical guidance Risk Mitigation developed? How does this impact the role of the community pharmacist? Join the BCPhA in a live webinar to discuss how COVID-19 has compounded the harms and challenges of the opioid overdose crisis and what approaches to consider to support people who use drugs and to stay safe and prevent the spread of COVID-19.
Learning Objectives
After attending this session, participants will be better able to:
- Discuss how COVID-19 pandemic has impacted people who use drugs and/or are on opioid agonist treatment (OAT).
- Review B.C. Centre on Substance Use’s (BCCSU) interim “Risk mitigation guidelines in the content of dual public health emergencies”.
- Review OAT prescribing and dispensing considerations during the pandemic.
- Discuss the temporary regulatory exemptions for controlled drugs and substances in response to COVID-19 pandemic.
About the Speaker: Blair Purda
Blair Purda graduated from the University of Manitoba in 1997 where his exposure to substance use disorder consisted of being told drugs were bad. Twenty plus years later and after a winding career path through various urban and suburban retail pharmacies, Blair has worked with a number of patients who use substances. He is now working in the Downtown East Side at clinics which specialize in opioid use disorder.
Accreditation
This program is non-accredited. Total learning hours is estimated at 1.0 hours.
Participants will receive a letter of participation after completion of the survey at the end of the webinar.